Actinogen Medical Limited
ATGGF
$0.025
$0.00525.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | 2.97M | 2.97M | 296.20K |
| Total Revenue | -- | -- | 2.97M | 2.97M | 296.20K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | 2.97M | 2.97M | 296.20K |
| SG&A Expenses | 1.17M | 1.20M | 1.26M | 1.26M | 1.11M |
| Depreciation & Amortization | 66.00K | 67.90K | 67.50K | 67.40K | 69.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.72M | 2.80M | 3.50M | 3.49M | 4.09M |
| Operating Income | -2.72M | -2.80M | -528.10K | -527.00K | -3.80M |
| Income Before Tax | -2.66M | -2.74M | -490.20K | -489.20K | -3.77M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.66M | -2.74M | -490.20K | -489.20K | -3.77M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.66M | -2.74M | -490.20K | -489.20K | -3.77M |
| EBIT | -2.72M | -2.80M | -528.10K | -527.00K | -3.80M |
| EBITDA | -2.67M | -2.75M | -474.30K | -473.30K | -3.74M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 2.92B | 2.92B | 2.28B | 2.28B | 2.06B |
| Average Diluted Shares Outstanding | 2.92B | 2.92B | 2.28B | 2.28B | 2.06B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |